by Bernard Siegel | Jun 6, 2017 | News & Opinions, Science
On December 2016, Mayor Bill De Blasio announced that the city’s next great industry is biotechnology. A lofty goal grounded in reality and backed with a $500 million funding commitment. Not long after this announcement, in April 2017, I visited New York to witness...
by Bernard Siegel | May 25, 2017 | News & Opinions, Policy
In December 2015, the Bipartisan Policy Center –a Washington, D.C. nonprofit think-tank– published a seminal paper entitled Advancing Regenerative Cellular Therapy -Medical Innovation Healthier Americans. This Report provided information about the nature of cell...
by Bernard Siegel | May 23, 2017 | News & Opinions, Science
Twelve years ago my nonprofit organization founded an annual conference that evolved into the World Stem Cell Summit. Over time, this event has brought together thousands of thought leaders and stakeholders from around the globe. All came with a shared passion, to...
by Bernard Siegel | May 4, 2017 | News & Opinions
Fifty years ago in a bygone era, my assignment was to deliver dozens of Smithfield gift hams at Christmastime in the Richmond suburb of Henrico County, Virginia. My father was a real estate developer embroiled in a challenging fight to rezone property for multi-family...
by Bernard Siegel | Apr 12, 2017 | News & Opinions, Policy
Columnist Mitchell Hiltzik savaged the La Jolla-based StemGenix Medical Center “The stem cell therapies offered by La Jolla clinic aren’t FDA approved, may not work- and cost $15,000” reads the title of his piece on the LA Times. StemGenix is the subject of a federal...
